Definition and diagnosis of occupational asthma

  • André Cartier
Part of the Progress in Inflammation Research book series (PIR)


Occupational asthma is a disease characterized by variable airflow limitation and/or hyperresponsiveness and/or inflammation due to causes and conditions attributable to a particular occupational environment and not to stimuli encountered outside the workplace. Two types of occupational asthma are distinguished based on their appearance after a latency period or not: the classical occupational asthma requiring a period of sensitization and irritant-induced asthma occurring after acute exposure to high concentrations of irritants. The diagnosis of occupational asthma should be based on objective means and cannot rely only on history (which is, although very sensitive, not sufficiently specific) or even on confirming the presence of asthma with positive skin tests to the relevant allergen/agent found at work. Inquiring about direct or indirect exposure to known sensitizers should be part of the questionnaire of any adult with new onset asthma. Monitoring of peak expiratory flows at and off work is a useful tool but may not be sufficiently sensitive or specific; combining it with monitoring of the provocative concentration of methacoline inducing a 20% fall in FEV1 and possibly sputum induction may improve the accuracy of the diagnosis. Specific inhalation challenges in the laboratory or in the workplace are the reference standard for confirming the diagnosis of occupational asthma. They are safe when done under the close supervision of an expert physician by trained personnel. Any new case of occupational asthma should be considered as a sentinel event.


Allergy Clin Immunol Peak Expiratory Flow Occupational Asthma Sputum Induction Sputum Eosinophil 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bernstein IL, Bernstein DI, Chan-Yeung M, Malo JL (2006): Defenition and classification of asthma in the workplace. In: IL Bernstein, M Chan-Yeung, JL Malo, DI Bernstein (eds): Asthma in the Workplace and related conditions. Taylor & Francis Group, New York, 1–8Google Scholar
  2. 2.
    Newman Taylor AJ (1980) Occupational asthma. Thorax 35: 241–245CrossRefPubMedGoogle Scholar
  3. 3.
    Brooks SM, Weiss MA, Bernstein IL (1985) Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 88: 376–384CrossRefPubMedGoogle Scholar
  4. 4.
    Brooks SM, Bernstein IL (1993): Reactive airways dysfunction syndrome or irritantinduced asthma. In: IL Bernstein, M Chan-Yeung, JL Malo, DI Bernstein (eds): Asthma in the Workplace. Marcel Dekker, New York, 533–549Google Scholar
  5. 5.
    Vandenplas O, Toren K, Blanc PD (2003) Health and socioeconomic impact of workrelated asthma. Eur Respir J 22: 689–697CrossRefPubMedGoogle Scholar
  6. 6.
    Larbanois A, Jamart J, Delwiche JP, Vandenplas O (2002) Socioeconomic outcome of subjects experiencing asthma symptoms at work. Eur Respir J 19: 1107–1113CrossRefPubMedGoogle Scholar
  7. 7.
    Beach J, Rowe BH, Blitz S, Crumley E, Hooton N, Russell K, et al (eds) (2005) Evidence Report/Technology Assessment No. 129. tDiagnosis and management of work-related asthma. Agency for Healthcare Research and Quality, Rockville, MDGoogle Scholar
  8. 8.
    Chan-Yeung M, Malo JL (1993): Natural history of occupational asthma. In: IL Bernstein, M Chan-Yeung, JL Malo, DI Bernstein (eds): Asthma in the Workplace. Marcel Dekker, New York, 299–322Google Scholar
  9. 9.
    Paggiaro PL, Vagaggini B, Bacci E, Bancalari L, Carrara M, Di Franco A, Giannini D, Dente FL, Giuntini C (1994) Prognosis of occupational asthma. Eur Respir J 7: 761–767CrossRefPubMedGoogle Scholar
  10. 10.
    Tarlo SM, Liss G, Corey P, Broder I (1995) A workers compensation claim population for occupational asthma — Comparison of subgroups. Chest 107: 634–641CrossRefPubMedGoogle Scholar
  11. 11.
    Malo JL, Ghezzo H, D’Aquino C, L’Archeveque J, Cartier A, Chan-Yeung M (1992) Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol 90: 937–944CrossRefPubMedGoogle Scholar
  12. 12.
    Malo JL, Lemiere C, Desjardins A, Cartier A (1997) Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 10: 1513–1515CrossRefPubMedGoogle Scholar
  13. 13.
    Malo JL, Ghezzo H, L’Archeveque J, Lagier F, Perrin B, Cartier A (1991) Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 143: 528–532PubMedGoogle Scholar
  14. 14.
    Burge PS (1982) Single and serial measurements of lung function in the diagnosis of occupational asthma. Eur J Respir Dis 63 (Suppl 23): 47–59Google Scholar
  15. 15.
    Bardy JD, Malo JL, Séguin P, Ghezzo H, Desjardins J, Dolovich J, Cartier A (1987) Occupational asthma and IgE sensitization in a pharmaceutical company processing psyllium. Am Rev Respir Dis 135: 1033–1038PubMedGoogle Scholar
  16. 16.
    Malo JL, Cartier A (1988) Occupational asthma in workers of a pharmaceutical company processing spiramycin. Thorax 43: 371–377CrossRefPubMedGoogle Scholar
  17. 17.
    Baur X, Huber H, Degens PO, Allmers H, Ammon J (1998) Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 33: 114–122CrossRefPubMedGoogle Scholar
  18. 18.
    Smith AB, Brooks SM, Blanchard J, Bernstein IL, Gallagher J (1980) Absence of airway hyperreactivity to methacholine in a worker sensitized to toluene diisocyanate. J Occup Med 22: 327–331CrossRefPubMedGoogle Scholar
  19. 19.
    Banks DE, Barkman WHJ, Butcher BT, Hammad YY, Rando RJ, Glindmeyer HWI, Jones RN, Weill H (1986) Absence of hyperresponsiveness to methacholine in a worker with methylene diphenyl diisocyanate (MDI)-induced asthma. Chest 89: 389–393CrossRefPubMedGoogle Scholar
  20. 20.
    Cockcroft DW, Mink JT (1979) Isocyanate-induced asthma in an automobile spray painter. Can Med Assoc J 121: 602–604PubMedGoogle Scholar
  21. 21.
    Hargreave FE, Ramsdale EH, Pugsley SO (1984) Occupational asthma without bronchial hyperresponsiveness. Am Rev Respir Dis 130: 513–515PubMedGoogle Scholar
  22. 22.
    Lemiere C, Cartier A, Dolovich J, Chan-Yeung M, Grammer L, Ghezzo H, L’Archeveque J, Malo JL (1996) Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 154: 329–333PubMedGoogle Scholar
  23. 23.
    Bernstein JA (2002) Material safety data sheets: Are they reliable in identifying human hazards? J Allergy Clin Immunol 110: 35–38CrossRefPubMedGoogle Scholar
  24. 24.
    Cartier A, Malo JL, Ghezzo H, McCants M, Lehrer SB (1986) IgE sensitization in snow crab-processing workers. J Allergy Clin Immunol 78: 344–348CrossRefPubMedGoogle Scholar
  25. 25.
    Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, Harris K, Patterson R (1989) Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 84: 507–514CrossRefPubMedGoogle Scholar
  26. 26.
    Bernstein DI, Cartier A, Côté J, Malo JL, Boulet LP, Wanner M, Milot J, L’Archeveque J, Trudeau C, Lummus Z (2002) Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 166: 445–450CrossRefPubMedGoogle Scholar
  27. 27.
    Beach J, Russell K, Blitz S, Hooton N, Spooner C, Lemiere C, Tarlo SM, Rowe BH (2007) A systematic review of the diagnosis of occupational asthma. Chest 131: 569–578CrossRefPubMedGoogle Scholar
  28. 28.
    Burge PS, O’Brien I, Harries M (1979) Peak flow rate records in the diagnosis of occupational asthma due to isocyanates. Thorax 34: 317–323CrossRefPubMedGoogle Scholar
  29. 29.
    Burge PS, O’Brien I, Harries M (1979) Peak flow rate records in the diagnosis of occupational asthma due to colophony. Thorax 34: 308–316CrossRefPubMedGoogle Scholar
  30. 30.
    Cartier A, Pineau L, Malo JL (1984) Monitoring of maximum expiratory peak flow rates and histamine inhalation tests in the investigation of occupational asthma. Clin Allergy 14: 193–196CrossRefPubMedGoogle Scholar
  31. 31.
    Côté J, Kennedy S, Chan-Yeung M (1990) Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol 85: 592–598CrossRefPubMedGoogle Scholar
  32. 32.
    Perrin B, Lagier F, L’Archeveque J, Cartier A, Boulet LP, Côté J, Malo JL (1992) Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J 5: 40–48PubMedGoogle Scholar
  33. 33.
    Girard F, Chaboillez S, Cartier A, Côté J, Hargreave FE, Labrecque M, Malo JL, Tarlo SM, Lemiere C (2004) An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med 170: 845–850CrossRefPubMedGoogle Scholar
  34. 34.
    Lemiere C (2004) The use of sputum eosinophils in the evaluation of occupational asthma. Curr Opin Allergy Clin Immunol 4: 81–85CrossRefPubMedGoogle Scholar
  35. 35.
    Moscato G, Godnic-Cvar J, Maestrelli P, Malo JL, Burge PS, Coifman R (1995) Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of the European Academy of Allergology and Clinical Immunology. American Academy of Allergy and Clinical Immunology. European Respiratory Society. American College of Allergy, Asthma and Immunology. Eur Respir J 8: 1605–1610CrossRefPubMedGoogle Scholar
  36. 36.
    Bright P, Burge PS (1996) Occupational lung disease. 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work. Thorax 51: 857–863CrossRefPubMedGoogle Scholar
  37. 37.
    Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, et al (2008) Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 134: 1S–41SCrossRefPubMedGoogle Scholar
  38. 38.
    Malo JL, Côté J, Cartier A, Boulet LP, L’Archeveque J, Chan-Yeung M (1993) How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Thorax 48: 1211–1217CrossRefPubMedGoogle Scholar
  39. 39.
    Côté J, Kennedy S, Chan-Yeung M (1993) Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax 48: 48–51CrossRefPubMedGoogle Scholar
  40. 40.
    Gannon PFG, Newton DT, Belcher J, Pantin CFA, Burge PS (1996) Development of OASYS-2 — A system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax 51: 484–489CrossRefPubMedGoogle Scholar
  41. 41.
    Bright P, Newton DT, Gannon PF, Pantin CF, Burge PS (2001) OASYS-3: Improved analysis of serial peak expiratory flow in suspected occupational asthma. Monaldi Arch Chest Dis 56: 281–288PubMedGoogle Scholar
  42. 42.
    Baldwin DR, Gannon P, Bright P, Newton DT, Robertson A, Venables K, Graneek B, Barker RD, Cartier A, Malo JL, et al (2002) Interpretation of occupational peak flow records: Level of agreement between expert clinicians and Oasys-2. Thorax 57: 860–864CrossRefPubMedGoogle Scholar
  43. 43.
    Chiry S, Cartier A, Malo JL, Tarlo SM, Lemiere C (2007) Comparison of peak expiratory flow variability between workers with work-exacerbated asthma and occupational asthma. Chest 132: 483–488CrossRefPubMedGoogle Scholar
  44. 44.
    Bérubé D, Cartier A, L’Archeveque J, Ghezzo H, Malo JL (1991) Comparison of peak expiratory flow rate and FEV1_in assessing bronchomotor tone after challenges with occupational sensitizers. Chest 99: 831–836CrossRefPubMedGoogle Scholar
  45. 45.
    Gautrin D, D’Aquino LC, Gagnon G, Malo JL, Cartier A (1994) Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at the outpatient clinic. Chest 106: 1419–1426CrossRefPubMedGoogle Scholar
  46. 46.
    Moscato G, Dellabianca A, Paggiaro P, Bertoletti R, Corsico A, Perfetti L (1993) Peak expiratory flow monitoring and airway response to specific bronchial provocation tests in asthmatics. Monaldi Arch Chest Dis 48: 23–28PubMedGoogle Scholar
  47. 47.
    Malo JL, Trudeau C, Ghezzo H, L’Archeveque J, Cartier A (1995) Do subjects investigated for occupational asthma through serial peak expiratory flow measurements falsify their results. J Allergy Clin Immunol 96: 601–607CrossRefPubMedGoogle Scholar
  48. 48.
    Quirce S, Contreras G, Dybuncio A, Chan-Yeung M (1995) Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma. Am J Respir Crit Care Med 152: 1100–1102PubMedGoogle Scholar
  49. 49.
    Lemiere C, Pizzichini MM, Balkissoon R, Clelland L, Efthimiadis A, O’Shaughnessy D, Dolovich J, Hargreave FE (1999) Diagnosing occupational asthma: Use of induced sputum. Eur Respir J 13: 482–488CrossRefPubMedGoogle Scholar
  50. 50.
    Krakowiak AM, Dudek W, Ruta U, Palczynski C (2005) Occupational eosinophilic bronchitis without asthma due to chloramine exposure. Occup Med (Lond) 55: 396–398CrossRefGoogle Scholar
  51. 51.
    Lemiere C, Efthimiadis A, Hargreave FE (1997) Occupational eosinophilic bronchitis without asthma: An unknown occupational airway disease. J Allergy Clin Immunol 100: 852–853CrossRefPubMedGoogle Scholar
  52. 52.
    Cartier A, Malo JL (1993): Occupational challenge tests. In: IL Bernstein, M Chan-Yeung, JL Malo, DI Bernstein (eds): Asthma in the Workplace. Marcel Dekker, New York, 215–248Google Scholar
  53. 53.
    Chan-Yeung M, Malo JL (1987) Occupational asthma. Chest 91: 130S–136SCrossRefPubMedGoogle Scholar
  54. 54.
    Canadian Thoracic Society (1989) Occupational asthma: Recommendations for diagnosis, management and assessment of impairment. Can Med Assoc J 140: 1029–1032Google Scholar
  55. 55.
    Cartier A, Bernstein IL, Burge PS, Cohn JR, Fabbri LM, Hargreave FE, Malo JL, McKay RT, Salvaggio JE (1989) Guidelines for bronchoprovocation on the investigation of occupational asthma. Report of the Subcommittee on Bronchoprovocation for Occupational Asthma. J Allergy Clin Immunol 84: 823–829CrossRefPubMedGoogle Scholar
  56. 56.
    EAACI (1992) Guidelines for the diagnosis of occupational asthma. Subcommittee on ‘Occupational Allergy’ of the European Academy of Allergology and Clinical Immunology. Clin Exp Allergy 22: 103–108CrossRefGoogle Scholar
  57. 57.
    Pepys J, Hutchcroft BJ (1975) Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 112: 829–859PubMedGoogle Scholar
  58. 58.
    Chan-Yeung M, McMurren T, Catonio-Begley F, Lam S (1993) Occupational asthma in a technologist exposed to glutaraldehyde. J Allergy Clin Immunol 91: 974–978CrossRefPubMedGoogle Scholar
  59. 59.
    Cartier A, Malo JL, Forest F, Lafrance M, Pineau L, St-Aubin JJ, Dubois JY (1984) Occupational asthma in snow crab-processing workers. J Allergy Clin Immunol 74: 261–269CrossRefPubMedGoogle Scholar
  60. 60.
    Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. (2000) Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161: 309–329PubMedGoogle Scholar
  61. 61.
    Cloutier Y, Lagier F, Lemieux R, Blais MC, St-Arnaud C, Cartier A, Malo JL (1989) New methodology for specific inhalation challenges with occupational agents in powder form. Eur Respir J 2: 769–777PubMedGoogle Scholar
  62. 62.
    Cloutier Y, Lagier F, Cartier A, Malo JL (1992) Validation of an exposure system to particles for the diagnosis of occupational asthma. Chest 102: 402–407CrossRefPubMedGoogle Scholar
  63. 63.
    Cloutier Y, Malo JL (1992) Update on an exposure system for particles in the diagnosis of occupational asthma. Eur Respir J 5: 887–890PubMedGoogle Scholar
  64. 64.
    Vandenplas O, Malo JL, Cartier A, Perreault G, Cloutier Y (1992) Closed-circuit methodology for inhalation challenge tests with isocyanates. Am Rev Respir Dis 145: 582–587PubMedGoogle Scholar
  65. 65.
    Lemiere C, Cloutier Y, Perrault G, Drolet D, Cartier A, Malo JL (1996) Closed-circuit apparatus for specific inhalation challenges with an occupational agent, formaldehyde, in vapor form. Chest 109: 1631–1635CrossRefPubMedGoogle Scholar
  66. 66.
    Banks DE, Tarlo SM, Masri F, Rando RJ, Weissman DN (1996) Bronchoprovocation tests in the diagnosis of isocyanate-induced asthma. Chest 109: 1370–1379CrossRefPubMedGoogle Scholar
  67. 67.
    Sostrand P, Kongerud J, Eduard W, Nilsen T, Skogland M, Boe J (1997) A test chamber for experimental hydrogen fluoride exposure in humans. Am Ind Hyg Assoc J 58: 521–525PubMedGoogle Scholar
  68. 68.
    Perrin B, Cartier A, Ghezzo H, Grammer L, Harris K, Chan H, Chan-Yeung M, Malo JL (1991) Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. J Allergy Clin Immunol 87: 630–639CrossRefPubMedGoogle Scholar
  69. 69.
    Vandenplas O, Delwiche JP, Jamart J, Vandeweyer R (1996) Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges. Thorax 51: 472–478CrossRefPubMedGoogle Scholar
  70. 70.
    Malo JL, Ghezzo H, L’Archeveque J, Cartier A (1990) Late asthmatic reactions to occupational sensitizing agents: frequency of changes in nonspecific bronchial responsiveness and of response to inhaled beta 2-adrenergic agent. J Allergy Clin Immunol 85: 834–842CrossRefPubMedGoogle Scholar
  71. 71.
    Cockcroft DW, Hoeppner VH, Werner GD (1984) Recurrent nocturnal asthma after bronchoprovocation with Western Red Cedar sawdust: association with acute increase in non-allergic bronchial responsiveness. Clin Allergy 14: 61–68CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser / Springer Basel 2010

Authors and Affiliations

  • André Cartier
    • 1
  1. 1.University of Montreal, Department of MedicineHôpital du Sacré-Coeur de MontréalMontréalCanada

Personalised recommendations